🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07733596
Starting soon Not applicable

Development of a Digital Acceptance and Commitment Therapy Intervention for Suicide Prevention in Adults Through Co-design

NCT07733596 · tracked via the Priya Life Science China tracker
Sponsor
The Hong Kong Polytechnic University
Phase
Not applicable
Started
2026-07-15
Last updated
2026-07-29

Condition(s) studied

SuicideCo-designSuicide Prevention

Investigational drug(s) / intervention(s)

Digital ACT Intervention

Digital ACT Intervention: A co-designed digital Acceptance and Commitment Therapy (ACT) intervention for suicide prevention

Study summary

Suicide is a major public health concern and there is a need for accessible and scalable interventions to support individuals experiencing suicidal thoughts. The aim of this study is to develop a digital Acceptance and Commitment Therapy (ACT) intervention for suicide prevention in Chinese adults through co-design. The study will involve literature review, interviews, and co-design activities to identify user needs, preferences, and contextual factors, and to develop the intervention. Following intervention development, a pilot study will be conducted to evaluate the feasibility, usability, acceptability, and user engagement of the intervention. Findings from this study will inform further refinement of the intervention and future evaluation studies.

Eligibility

Sex
ALL
Min age
18 Years
Max age
Healthy volunteers
No
* Inclusion Criteria Lived experience participants 1. Aged 18 years or older; 2. Have experienced suicidal thoughts and/or behaviors; 3. Able to read and communicate in Chinese; Professionals <!-- --> 1. Aged 18 years or older; 2. Professionals with experience relevant to suicide prevention, Acceptance and Commitment Therapy (ACT), digital mental health, or related fields; * Exclusion Criteria 1. Unable to provide informed consent or participate in study activities; 2. Currently experiencing acute suicide risk requiring immediate intervention; 3. Severe cognitive impairment or active psychotic symptoms that would prevent participation.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
The Hong Kong Polytechnic University Hong Kong China

More The Hong Kong Polytechnic University trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07733596 on ClinicalTrials.gov ↗ ← All trials in China